ערך בספרים למניה: CENTOGENE, N.V. (CNTG)

The current book value per share of Centogene N.V. (CNTG), where the current mark equals 0.00, correlates with the performance of sector leaders in genetics that adhere to strict medical compliance. Rising demand for molecular diagnostics of orphan pathologies is expanding the number of partners among pharma behemoths. The business's profitability is based on the implementation of complex laboratory tests and the utilization of unique clinical data sets.

The expert management of Centogene N.V. (CNTG) in the field of genetic analysis ensures asset transparency, which is directly reflected in the current book value per share. This indicator is calculated as the difference between all company assets and liabilities divided by the number of shares, determining the intrinsic value of the business and protecting the investor from overpaying relative to actual capital.